- ISIN
- US0396971071
- CUSIP
- 039697107
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jun 19, 2014
Highlights
- Market Cap
- $1.57B
- Enterprise Value
- $1.74B
- EPS (TTM)
- -$0.24
- Total Revenue (TTM)
- $427.68M
- Gross Profit (TTM)
- $395.63M
- EBITDA (TTM)
- -$28.55M
- Year Range
- $3.56 - $8.40
- Target Price
- $17.00
- ROA (TTM)
- -11.51%
- ROE (TTM)
- -39.07%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ARDX Performance Chart
Ardelyx, Inc. (ARDX) is up 9.3% since the beginning of the year. At $6 per share, ARDX is trading 24.2% below its 52-week high of $8. Investors who bought $1,000 worth of ARDX shares 5 years ago would now be looking at an investment worth $865.
Loading charts...
Returns By Period
Ardelyx, Inc. (ARDX) has returned 9.26% so far this year and 78.93% over the past 12 months. Over the last ten years, ARDX has returned -2.30% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Ardelyx, Inc.
- 1D
- 5.29%
- 1M
- 4.26%
- YTD
- 9.26%
- 6M
- 9.08%
- 1Y
- 78.93%
- 3Y*
- 20.95%
- 5Y*
- -2.85%
- 10Y*
- -2.30%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
ARDX Monthly Returns History
Based on dividend-adjusted daily data since Jun 19, 2014, ARDX's average daily return is +0.12%, while the average monthly return is +2.07%. At this rate, an investment would double in approximately 2.8 years.
Historically, 49% of months were positive and 51% were negative. The best month was Mar 2023 with a return of +66.3%, while the worst month was Jul 2021 at -77.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 8 months.
On a daily basis, ARDX closed higher 47% of trading days. The best single day was Sep 3, 2019 with a return of +71.2%, while the worst single day was Jul 20, 2021 at -73.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 31.90% | -14.82% | -8.55% | 5.68% | -4.58% | 5.46% | 9.26% | ||||||
| 2025 | 5.72% | 0.00% | -8.40% | 12.12% | -33.33% | 6.81% | 8.16% | 50.00% | -13.36% | 9.98% | -4.29% | 0.52% | 14.99% |
| 2024 | 40.81% | 6.76% | -21.67% | -12.33% | 7.19% | 8.02% | -25.10% | 11.35% | 11.49% | -14.80% | -3.41% | -10.58% | -18.23% |
| 2023 | 2.81% | -1.71% | 66.32% | -6.89% | -25.11% | 1.50% | 16.22% | 8.12% | -4.23% | -3.19% | 14.18% | 37.47% | 117.54% |
| 2022 | -24.89% | -6.80% | 38.96% | -23.09% | -20.25% | -10.12% | 18.33% | 35.80% | 25.54% | 26.05% | 14.67% | 65.70% | 159.09% |
| 2021 | 4.95% | -5.01% | 2.64% | 10.42% | -2.19% | 6.01% | -77.04% | -18.97% | -6.38% | -8.33% | -5.79% | -3.51% | -83.00% |
Benchmark Metrics
Ardelyx, Inc. has an annualized alpha of 17.30%, beta of 1.15, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since June 19, 2014.
- This stock participated in 131.76% of S&P 500 Index downside but only 50.99% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 17.30%
- Beta
- 1.15
- R²
- 0.06
- Upside Capture
- 50.99%
- Downside Capture
- 131.76%
Return for Risk
Risk / Return Rank
ARDX ranks 78 for risk / return — better than 78% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Ardelyx, Inc. (ARDX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARDX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.74 | ||
| Sortino ratioReturn per unit of downside risk | -0.46 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 1.37 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 2.37 | 2.78 | -0.42 |
| Martin ratioReturn relative to average drawdown | 4.59 | 12.44 | -7.85 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Ardelyx, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Ardelyx, Inc. was 98.45%, occurring on Jun 14, 2022. The portfolio has not yet recovered.
The current Ardelyx, Inc. drawdown is 80.63%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -98.45%Jun 2022 | 7y 6mo | — | 11y 6moDec 2014 - now |
2014 bear market2014 | -43.00%Aug 2014 | 1mo 9d | 1mo 19d | 2mo 28dJul 2014 - Oct 2014 |
2014 bear market2014 | -21.22%Oct 2014 | 2d | 1mo 18d | 1mo 20dOct 2014 - Nov 2014 |
2014 pullback2014 | -2.69%Jun 2014 | 0s | 4d | 4dJun 2014 - Jun 2014 |
2014 pullback2014 | -2.28%Jun 2014 | 0s | 2d | 2dJun 2014 - Jun 2014 |
Drawdown Indicators
| ARDX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.45% | -56.78% | -41.67% |
Max Drawdown (1Y)Largest decline over 1 year | -33.54% | -9.10% | -24.44% |
Max Drawdown (3Y)Largest decline over 3 years | -66.32% | -18.90% | -47.42% |
Max Drawdown (5Y)Largest decline over 5 years | -93.76% | -25.43% | -68.33% |
Max Drawdown (10Y)Largest decline over 10 years | -96.82% | -33.92% | -62.90% |
Current DrawdownCurrent decline from peak | -80.63% | -1.80% | -78.83% |
Average DrawdownAverage peak-to-trough decline | -77.37% | -10.71% | -66.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.26% | 2.03% | +15.23% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Ardelyx, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Ardelyx, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ARDX relative to other companies in the Biotechnology industry. Currently, ARDX has a P/S ratio of 3.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ARDX in comparison with other companies in the Biotechnology industry. Currently, ARDX has a P/B value of 10.5. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ARDX
Add Ardelyx, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ARDX